Gibson, Dunn & Crutcher LLP advised Biosynth in the transaction. Biosynth, a portfolio company of KKR, announced its acquisition of celares GmbH. The terms and conditions of the...
Standard 1 Year Membership Required
You must be a Standard 1 Year member to access this content.
Already a member? Log in here